This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why Chemours (CC) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Chemours (CC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Sociedad Quimica (SQM) Q2 Earnings Lag Estimates, Sales Beat
by Zacks Equity Research
Sociedad Quimica (SQM) benefits from a significant increase in lithium prices in the second quarter.
CC or PPG: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CC vs. PPG: Which Stock Is the Better Value Option?
Has Chemours (CC) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Chemours (CC) and Ryerson Holding (RYI) have performed compared to their sector so far this year.
Chemours (CC) Stock Up 25% in 6 Months: What's Driving It?
by Zacks Equity Research
Chemours (CC) gains on healthy demand, strong execution and its cost-reduction and pricing actions.
Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for JPME
Should Value Investors Buy Chemours (CC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CC vs. ALB: Which Stock Is the Better Value Option?
by Zacks Equity Research
CC vs. ALB: Which Stock Is the Better Value Option?
Are Basic Materials Stocks Lagging Chemours (CC) This Year?
by Zacks Equity Research
Here is how Chemours (CC) and Silica Holdings (SLCA) have performed compared to their sector so far this year.
Chemours (CC) Earnings and Revenues Top Estimates in Q2
by Zacks Equity Research
Higher prices contribute favorably to Chemours' (CC) top-line growth in the second quarter.
Chemours (CC) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of 33.10% and 5.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemours (CC) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Chemours' (CC) second-quarter performance is likely to reflect the increasing adoption of Opteon refrigerants and the benefits of cost-cutting measures.
Earnings Preview: LyondellBasell (LYB) Q2 Earnings Expected to Decline
by Zacks Equity Research
LyondellBasell (LYB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Chemours (CC) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Best Growth Stocks to Buy for June 29th
by Zacks Equity Research
CIB, CC and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 29, 2022.
New Strong Buy Stocks for June 27th
by Zacks Equity Research
BSAC, CPLP, CC, OTTR, and DELL have been added to the Zacks Rank #1 (Strong Buy) List on June 27, 2022.
Best Value Stocks to Buy for June 27th
by Zacks Equity Research
CPLP, CC, and DELL made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 27, 2022.
Best Income Stocks to Buy for June 27th
by Zacks Equity Research
BSAC, CPLP, and CC made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 27, 2022.
Chemours (CC) Stock Jumps 7.4%: Will It Continue to Soar?
by Zacks Equity Research
Chemours (CC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CC vs. FMC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CC vs. FMC: Which Stock Is the Better Value Option?
Are Investors Undervaluing Chemours (CC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Momentum Stocks to Buy for June 22nd
by Zacks Equity Research
CC, KR, and OSBC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 22, 2022.
Chemours (CC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Chemours (CC) closed the most recent trading day at $31.44, moving -0.47% from the previous trading session.
Nutrien (NTR) to Increase Fertilizer Production & Return Capital
by Zacks Equity Research
Nutrien (NTR) intends to boost annual potash manufacturing capacity to 18 million tons by 2025 due to the supply uncertainty from Eastern Europe.